Search clinical trials for: Donepepzil

Total 301 results

Eisai Inc.

Completed

Safety, Tolerability, and Efficacy of Donepezil (Aricept) in Parkinson' s Disease (PD) Patients With Dementia

Parkinson's Disease | Dementia

United Kingdom
University Hospital, Lille
Innovative Medicines Initiative

Completed

Prediction of Cognitive Properties of New Drug Candidates for Neurodegenerative Diseases in Early Clinical Development (PharmacogWP3)

Alzheimer Disease | Battery

France
Merck Sharp & Dohme LLC

Unknown

Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005)

Mild Cognitive Impairment | Alzheimer's Disease
Pfizer

Completed

A Randomized, Placebo-Controlled Trial to Examine the Efficacy of Oral Donepezil in Subjects With MCI

Alzheimer's Disease

United States
Eisai Inc.
Eisai Limited

Completed

Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's Disease

Alzheimer's Disease

United States
Eisai Co., Ltd.

Completed

A Double-blind Study of E2020 (Donepezil Hydrochloride) in Patients With Dementia With Lewy Bodies (DLB) (Study E2020-J081-431)

Dementia With Lewy Bodies (DLB)

Japan
Corium, Inc.

Completed

A Phase 1, Corplex™ Donepezil Transdermal System Compared to Oral Aricept®

Alzheimer Disease

United States
Samsung Medical Center
Eisai Korea Inc.

Completed

Clinical Trial of Donepezil Between the Patients With Alzheimer's Disease and Mixed Dementia

Dementia | Alzheimer's Disease

Korea, Republic of
Eisai Co., Ltd.

Completed

A Study of E2020 in Patients With Dementia With Lewy Bodies (DLB), Followed by a Long-term Extension Phase

Dementia With Lewy Bodies (DLB)

Japan
Eisai Inc.
Pfizer

Terminated

Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 6 To 10

Cognitive Dysfunction | Down Syndrome

United States
Eisai Inc.
Pfizer

Terminated

Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17

Cognitive Dysfunction | Down Syndrome

United States
Eisai Inc.

Completed

An Evaluation Of The Efficacy And Safety Of Donepezil Hydrochloride (E2020) In Migraine Prophylaxis

Migraine Headache

United States
The First Affiliated Hospital with Nanjing Medical...

Unknown

Clinical Efficacy of Ginkgo Biloba Extract in the Treatment of Alzheimer's Disease

Alzheimer's

China
Shanghai Synergy Pharmaceutical Sciences Co., Ltd.

Completed

Safety and Pharmacokinetic of Donepezil Pamoate in Healthy Subjects

AD

China
Ever Neuro Pharma GmbH
acromion GmbH

Completed

Comparative Study to Test Safety and Efficacy of Neurotrophic and Cholinergic Treatment of Alzheimer's Disease (Combi)

Alzheimer Disease

Spain
Teva Pharmaceuticals USA

Completed

10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Non-Fasting Conditions

Healthy

United States
Stanford University

Completed

An Open-Label Trial of Donepezil in Fragile X Syndrome

Fragile X Syndrome

United States
Eisai Inc.

Completed

A 28-Week Open Label Extension Study Evaluating Safety and Tolerability of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment

Mild Cognitive Impairment

United States
Samsung Medical Center
Eisai Korea Inc.

Completed

Clinical Trial of Donepezil Between the Naive Group and the Switching Group

Dementia | Alzheimer's Disease

Korea, Republic of
Eisai Co., Ltd.

Completed

A Study of Donepezil Hydrochloride in Patients With Dementia Associated With Cerebrovascular Disease

Dementia Associated With Cerebrovascular Disease

Korea, Republic of
Pfizer

Terminated

Assessment Of The Effects Of Single Doses Of An Investigational Drug, Given Alone Or With Donepezil, On Scopolamine-Induced Changes In Memory And Learning In Healthy Adults

Healthy

United States
Kessler Foundation
Pfizer

Unknown

Aricept to Improve Functional Tasks in Vascular Dementia

Stroke | Vascular Dementia | Memory Deficits

United States
Teva Pharmaceuticals USA

Completed

10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Fasting Conditions.

Healthy

United States
Boehringer Ingelheim

Completed

Investigation of Pharmacokinetic Drug-drug Interaction of BI 409306 and Donepezil in Healthy Male and Female Subjects

Healthy

Germany
Dongzhimen Hospital, Beijing

Completed

Efficacy and Safety of Tianzhi Granule in Mild to Moderate Vascular Dementia

Vascular Dementia

China
Lawson Health Research Institute

Completed

Donepezil and the Risk of Falls in Seniors With Cognitive Impairment

Mild Cognitive Impairment (MCI) | Gait | Falls | Balance

Canada
Beersheva Mental Health Center

Unknown

Donepezil Treatment of Psychotic Symptoms in Dementia Patients

Dementia of Alzheimer Type

Israel
Merck Sharp & Dohme LLC

Completed

A Study to Test the Performance of the CogState Computerized Neuropsychological Battery in Patients With Alzheimer's Disease (0000-086)(COMPLETED)

Alzheimer's Disease
Samsung Medical Center
Dong-A Pharmaceutical Co., Ltd.

Unknown

Zydena on Cognitive Function of Alzheimer's Disease Patients

Alzheimer's Disease

Korea, Republic of
Groupe Hospitalier Pitie-Salpetriere
Institut National de la Santé Et de la Recherche Médicale, France

Unknown

Study of the Distractibility Syndrome in Patients With Progressive Supranuclear Palsy

Supranuclear Palsy, Progressive

France
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

The Effect of Donepezil in Radiotherapy-related Cognitive Impairment.

Cognitive Impairment | Radiation Injuries

China
Eisai Co., Ltd.

Completed

Post-marketing Surveillance of Donepezil Hydrochloride - Investigation of Long Term Safety and Efficacy of Aricept as Well as Its Proper Use Information in Patients With Dementia With Lewy Bodies (DLB).

Dementia With Lewy Body Disease

Japan
Sanofi

Terminated

Effect on Cognitive Performance and Safety/Tolerability of SSR180711C in Mild Alzheimer's Disease

Alzheimer's Disease

France
GlaxoSmithKline

Completed

SB-742457 And Donepezil In Alzheimer's Disease

Alzheimer's Disease

Bulgaria, Estonia, Chile, Russian Federation, Slovakia, Germany, Austria, United Kingdom
National Institute on Aging (NIA)

Completed

Brain Imaging and Mental Disorders of Aging Intervention

Cognition Disorders

United States
Eisai Korea Inc.

Completed

Alzheimer's Disease Long-term Follow-up Study (ALF Study)

Alzheimer's Disease

Korea, Republic of
Corium, Inc.

Completed

A Study to Evaluate the Effect of Heat Application on the Delivery Profile of Corplex™ Donepezil Transdermal Delivery System (TDS)

Alzheimer's Disease

United States
Associação Fundo de Incentivo à Pesquisa

Unknown

Donepezil, Residual Excessive Daytime Sleepiness, Obstructive Sleep Apnea

OSA | Sleepiness

Brazil
Eisai Inc.
Pfizer

Completed

Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease

Dementia | Alzheimer's Disease

United States, Canada, United Kingdom, Australia, France, Ireland
Merck Sharp & Dohme LLC

Terminated

A Study to Evaluate the Effects of MK-0249 and an Alzheimer's Disease Medication on Cognitive Function in Adults With Alzheimer's Disease (MK-0249-023)

Dementia | Alzheimer's Disease
Eisai Inc.
Eisai Limited

Completed

Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children With Attention Impairment Following Cancer Treatment

Attention Impairment

United States, Netherlands, France, Spain, United Kingdom, Germany, Argentina, Canada, Australia, Chile
Corium, Inc.

Completed

A Skin Irritation Assessment of Once-Weekly Corplex™ Donepezil Transdermal Delivery System

Skin Irritation | Sensitization

United States
Per Borghammer
Lundbeck Foundation

Completed

Study to Investigate the Ability of [11C]Donepezil PET to Image the Parasympathetic Nervous System

Parkinson's Disease

Denmark
AbbVie (prior sponsor, Abbott)

Completed

Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

United States, Poland, Russian Federation, South Africa, Ukraine, United Kingdom
Eisai Co., Ltd.

Completed

Pharmacokinetics Study of Donepezil HCl in Subjects Receiving Haemodialysis.

End-Stage Renal Disease

Japan
Eisai Inc.
Pfizer

Withdrawn

Evaluating The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's Disease

Severe Alzheimer's Disease

United States
Eisai Inc.
Pfizer

Completed

The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility

Mild to Severe Alzheimer's Disease

United States
Corium, Inc.

Completed

A Clinical Study to Evaluate the Pharmacokinetics (PK) of Corplex™ Donepezil Transdermal Delivery System (TDS) Applied to Different Body Locations

Alzheimer's Disease

United States
Asan Medical Center
Seoul St. Mary's Hospital; Seoul National University Bundang Hospital; Eisai... and other collaborators

Completed

Optimal Dose Escalation Strategy to Successful Achievement of High Dose Donepezil 23mg (ODESA)

Alzheimer's Disease

Korea, Republic of
Central South University

Unknown

A Double-blind, Placebo-controlled Trial of Donepezil Adjunctive Treatment for Cognitive Impairment in Schizophrenia

Schizophrenia | Impaired Cognition

China

3

Subscribe